Kinnate Biopharma Inc. (KNTE)
NASDAQ: KNTE
· Real-Time Price · USD
2.65
-0.01 (-0.38%)
At close: Apr 02, 2024, 10:00 PM
Kinnate Biopharma Cash Flow Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Net Income | -112.65M | -127.15M | -127.16M | -122.31M | -116.27M | -110.87M | -104.83M | -99.21M | -89.76M | -77.31M | -63.11M | -49.28M |
Depreciation & Amortization | 799K | 791K | 778K | 749K | 604K | 450K | 294K | 150K | 123K | 111K | 106K | 98K |
Stock-Based Compensation | 19.92M | 21.03M | 20.73M | 20.21M | 19.58M | 18.94M | 18.12M | 17M | 15.02M | 11.94M | 8.49M | 5.14M |
Other Working Capital | 1.37M | -505K | -429K | -961K | -332K | -5.01M | -3.72M | -3.92M | -3.54M | 1.03M | 438K | 2.26M |
Other Non-Cash Items | -4.06M | -11.2M | -5.79M | -536K | 682K | 2.68M | 3.1M | 3.27M | 3.13M | 1.42M | 883K | -7.28M |
Deferred Income Tax | -343K | 7.68M | 3.74M | n/a | n/a | -1.19M | -1.19M | -1.19M | -1.19M | n/a | n/a | 7.61M |
Change in Working Capital | -3.7M | 2.42M | 6.15M | 6.22M | 6.37M | 2.18M | -284K | 1.27M | 1.62M | 1.52M | 927K | 2.75M |
Operating Cash Flow | -100.04M | -106.43M | -101.55M | -95.67M | -89.03M | -87.81M | -84.79M | -78.71M | -71.06M | -62.32M | -52.7M | -40.95M |
Capital Expenditures | n/a | -90K | -153K | -712K | -2.72M | -3.33M | -3.3M | -2.78M | -769K | 262K | 69K | -4K |
Cash Acquisitions | -9.18M | -62.19K | -79.21K | -113.93K | -58.5K | 33.73M | 33.75M | 33.77M | 33.77M | n/a | n/a | n/a |
Purchase of Investments | -154.72M | -181.01M | -190.26M | -136.05M | -176.53M | -161.61M | -138.02M | -151.09M | -247.14M | -216.61M | -201.64M | -169.63M |
Sales Maturities Of Investments | 264.59M | 285.84M | 269.47M | 249.98M | 172.42M | 142.88M | 87.3M | 44.53M | 33.57M | n/a | n/a | n/a |
Other Investing Acitivies | 44.54K | 62.19K | 79.21K | 113.93K | 58.5K | -33.73M | 23.83K | n/a | n/a | 2.09M | -31.68M | -31.68M |
Investing Cash Flow | 100.74M | 104.74M | 79.06M | 113.22M | -6.83M | -22.06M | -20.25M | -75.57M | -180.57M | -214.26M | -233.25M | -201.31M |
Debt Repayment | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 58K | 58K | 58K |
Dividend Paid | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Financial Acitivies | 1.32M | -7.62M | -7.48M | -8.08M | 1.16M | 1.52M | 1.53M | 36.36M | 36.24M | 289.41M | 386.38M | 350.91M |
Financial Cash Flow | 1.32M | -7.81M | -7.86M | -9.11M | 1.16K | 1.52K | 1.53K | 36.36K | 36.24K | 253.76M | 350.93M | 350.91M |
Net Cash Flow | 2.01M | -9.31M | -29.98M | 9.47M | -94.7M | -108.35M | -103.52M | -117.92M | -215.4M | 12.83M | 100.43M | 108.65M |
Free Cash Flow | -100.04M | -106.52M | -101.7M | -96.38M | -91.75M | -91.14M | -88.09M | -81.49M | -71.83M | -62.06M | -52.63M | -40.95M |